• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Opexa Therapeutics Inc

+ Add to Watchlist

P6NN:GR

1.080 EUR 0.100 10.20%

As of 02:12:02 ET on 04/17/2014.

Snapshot for Opexa Therapeutics Inc (P6NN)

Open: 1.066 Day's Range: 1.053 - 1.080 Volume: 0
Previous Close: 0.980 52wk Range: 0.900 - 2.710 1-Yr Rtn: -14.42%

Stock Chart for P6NN

No chart data available.
  • P6NN:GR 1.080
  • 1D
  • 1M
  • 1Y
0.980
Interactive P6NN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for P6NN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4600
Est. PEG Ratio -
Market Cap (M EUR) 29.75
Shares Outstanding (M) 27.55
30 Day Average Volume 550
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for P6NN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for P6NN

Opexa Therapeutics, Inc. is biotechnology company. The company develops cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, pancreatic, and cardiac conditions. Opexa holds a worldwide license for an autologous T cell vaccine for rheumatoid arthritis.

Neil K WarmaPresident/CEOKarthik RadhakrishnanChief Financial Officer
Donna R RillChief Development Officer
More Company Profile & Key Executives for P6NN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil